Case Study

Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial

November 18, 2024June 25th, 2025
Optimizing-Early-Stage-Oncology-A-Strategic-Approach-to-Dose-Escalation-and-Expansion-in-Phase-I-Trials1_featured

Optimizing Early-Stage Oncology: TFS’s Strategic Approach to a Dose Escalation and Expansion Phase I Trial

Discover how a U.S. biotech company partnered with TFS HealthScience to manage a Phase I oncology trial for a new treatment targeting advanced epithelial tumors. The collaboration covered regulatory consulting, site identification, clinical monitoring, and other services to optimize dose escalation and expansion phases. TFS’s expertise streamlined operations, ensuring efficiency and adherence to regulatory standards.

What You’ll Learn:

  • How a specialized study team handles seamless trial execution & complex procedures effectively
  • The importance of proactive site selection, including a backup site, for enrollment speed & risk reduction
  • How prompt data reviews & safety updates allow for timely recruitment & study completion
  • The impact of skillful management on slot allocation, patient tracking, & data cleaning

Learn more about our related services and resources:

TFS Oncology & Hematology

Connect with Us

Contact us today to discover how TFS can be your strategic CRO partner in clinical development.

Let's Talk

Learn More About Our Oncology & Hematology Expertise

ASCO Oncology
10 oncology trial readouts to watch for at ASCO 2026Article

10 oncology trial readouts to watch for at ASCO 2026

Biomarker-defined populations. Rare cancers. Multi-country designs. As ASCO 2026 approaches, TFS HealthScience outlines the ten oncology trials that matter most and what they mean for sponsors planning their next programme.
The Value of Cross-Functional Expertise in Complex Oncology Clinical TrialsArticle

The Value of Cross-Functional Expertise in Complex Oncology Clinical Trials

Experienced Oncology CROs with cross-functional expertise strengthen complex oncology clinical trials and accelerates clinical development.
Customisation, partnerships and AI the keys to the future of clinical trials
From Strategy to Patients: Adaptability and Innovation in Trial DesignArticle

From Strategy to Patients: Adaptability and Innovation in Trial Design

Explore how adaptability, innovation, and patient focus can help sponsors rethink trial execution, from smarter sourcing models to the role of AI in oncology.